Showing results (751-760 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|November 3, 2024
Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm studySergio Harari, Davide Elia, Antonella Caminati, et al.
The Lancet. Respiratory Medicine|August 16, 2024
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world studyPierre-Régis Burgel, Isabelle Sermet-Gaudelus, Emmanuelle Girodon, et al.
The Lancet. Respiratory Medicine|August 19, 2024
Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab-ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trialYoshimasa Shiraishi, Shogo Nomura, Shunichi Sugawara, et al.
The Lancet. Respiratory Medicine|November 4, 2023
Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trialSanjay Ramakrishnan, Helen Jeffers, Beverly Langford-Wiley, et al.
The Lancet. Respiratory Medicine|November 18, 2023
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFengcai Zhu, Shoujie Huang, Xiaohui Liu, et al.
The Lancet. Respiratory Medicine|November 19, 2023
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trialBern-Thomas Nyang'wa, Catherine Berry, Emil Kazounis, et al.
The Lancet. Respiratory Medicine|November 17, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trialFrances C Hall, Joseph Cheriyan, Andrew P Cope, et al.
The Lancet. Respiratory Medicine|August 17, 2023
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and managementKaren M Olsson, Tamera J Corte, Jan C Kamp, et al.
The Lancet. Respiratory Medicine|January 23, 2024
Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trialClaire Dahyot-Fizelier, Sigismond Lasocki, Thomas Kerforne, et al.
The Lancet. Respiratory Medicine|December 24, 2023
Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trialT Douglas Bradley, Alexander G Logan, Geraldo Lorenzi Filho, et al.
Pageof 104